FDA Inspection 886479 — ImprimisRx NJ LLC

ImprimisRx NJ LLC — FEI 3003348498

The FDA completed an inspection of ImprimisRx NJ LLC on July 2, 2014 in Ledgewood, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 2, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ledgewood, NJ (United States)